GovChime
Notice ID: dc050f9f27f84e64b3fb0c6840810d9bCombined Synopsis/Solicitation

Regulatory Support for FDA Pre-IND Meeting: QGRFT for the Prevention of SARS-CoV-2 Infection

Archived on July 2, 2020. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:59 AM UTC−04:00
Posted
June 15, 2020
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
541990: All Other Professional, Scientific, and Technical Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95020Q00145
Notice ID
dc050f9f27f84e64b3fb0c6840810d9b

Description

Amendment 1 is issued on June 15, 2020 and amends the following: 1. The Statement of Work is amended to include the estimated number of hours for this requirement. 2. The Request for Quotations is amended to include a suggested format for price information. The revised Statement of Work and Request for Quotations are attached and replace the original versions. The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires regulatory and operational support for a pre-Investigational New Drug (IND) application meeting with the US Food and Drug Administration (FDA). This pre-IND application meeting is for the preclinical development of Q-Griffithsin (QGRFT), which may have therapeutic value as a preventative against SARS-CoV-2, the causative agent of the current COVID-19 pandemic. QGRFT data is proprietary to NCATS collaborators at the University of Louisville Research Foundation (ULRF) and the contractor must work collaboratively with ULRF and NCATS throughout the entire period of performance. Due to the urgency of supporting the development of treatment for COVID-19, the awardee must be capable of beginning work with QGRFT immediately upon contract execution. See attached Request for Quotations, Statement of Work, and related attachments for complete requirement details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95020Q00145
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentJun 9, 2020

    Regulatory Support for FDA Pre-IND Meeting: QGRFT for the Prevention of SARS-CoV-2 Infection

    Notice dc050f9f27f84e64b3fb0c6840810d9b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95020Q00145

Archive Date

Jul 2, 2020

Office Address

Bethesda, MD, 20892